{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:14:55Z","timestamp":1779290095585,"version":"3.51.4"},"reference-count":3,"publisher":"Elsevier BV","issue":"9333","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1016\/s0140-6736(02)09798-2","type":"journal-article","created":{"date-parts":[[2002,10,9]],"date-time":"2002-10-09T15:39:34Z","timestamp":1034177974000},"page":"645","source":"Crossref","is-referenced-by-count":20,"title":["Drug-induced systemic lupus erythematosus and TNF-\u03b1 blockers"],"prefix":"10.1016","volume":"360","author":[{"given":"GF","family":"Ferraccioli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Assaloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Perin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(02)09798-2_bib1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(02)09798-2_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/40.1.89","article-title":"Incomplete lupus erythematosus: results of a multicentre study under the supervision of the Eular standing committee on International Clinical Studies including therapeutic trials (ESCICIT)","volume":"40","author":"Swaak","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/S0140-6736(02)09798-2_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.61.4.358","article-title":"Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence of a possible association with infections","volume":"82","author":"Ferraccioli","year":"2002","journal-title":"Ann Rheum Dis"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673602097982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673602097982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T11:24:17Z","timestamp":1554895457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673602097982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":3,"journal-issue":{"issue":"9333","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S0140673602097982"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(02)09798-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}